This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA1017509; GEO: GSE243278 |
| Type | Umbrella project |
| Submission | Registration date: 14-Sep-2023
Benaroya Research Institute |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 117 |
| Other datasets |
| BioSample | 117 |
| GEO DataSets | 3 |
A phase II randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Other | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA1017390 | Homo sapiens | Maintenance of beta cell function in adolescent T1D subjects treated with a single dose of polyclonal expanded Treg is linked to lower ex vivo Treg expansion (Benaroya Research Institute) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA1017505 | Homo sapiens | Response to Treg therapy is linked to rate of ex vivo Treg expansion (Benaroya Research Institute) |
|